Skip to main content

Report: Health Care to be Major Driver of Houston Economy in Years Ahead

Published Oct 28, 2020 by A.J. Mistretta

GHP_Maternal Health Care_Medical

Over the next 16 years, about 1 in 4 of all new jobs added in the Houston region will be in the health care sector, but not properly preparing the workforce pipeline for those positions could cost the region billions. 

According to a new report from Center for Houston’s Future, the health care sector is likely to generate a baseline GDP of $26 billion for the region by 2036. But failing to adequately develop the talent pipeline to assume new jobs in the industry could cost Houston $18.6 billion in lost GDP and 111,000 potential jobs, the 62-page report found. 

The report, Houston’s Economic Future: Health Care, focusing on both the economic vitality of the region’s health care system and assessing our community’s health. 

Focusing on cultivating the region’s life sciences sector could yield an additional $13 billion in GDP and 73,000 additional jobs by 2036, the report found. 

The Center developed a unique economic forecasting tool to analyze the impact of various health-care-related scenarios on the region’s future employment growth and GDP. The organization conducted two surveys—one pre-Covid-19 in January and another in September—with regional employers. More than 50 health care experts contributed via focus groups and interviews, and some 100 executives in Greater Houston completed the Center’s health care surveys. 

The report profiles community health in the region, including outcomes and access to care. It discusses key trends currently reshaping how health care will be delivered and funded. These include telehealth and artificial intelligence.

The report details findings from the survey, including:

  • Employers widely see Covid-19 as a transformational event that will reshape the entire health care system. 
  • 59% of respondents said the pandemic has made them more likely to support an expansion of Medicaid in Texas.
  • The pandemic has drastically changed employers’ projections of how their health care costs will rise. In January, four in 10 expected costs to rise by over 10% in the next five years. Today, 65% believe this will be the case.

The report also includes a reflection on lessons learned from the region’s response to Covid-19, including:

  • Promoting health equity will facilitate a better pandemic response. Foremost, this means reducing the number of uninsured in Houston.
  • Adopting models of providing care such as value-based care would strengthen the region’s ability to weather a crisis by transferring financial risk from providers to payors.

In light of the report’s findings, the Center acknowledged that a coordinated public health response and thriving health system requires collaboration across the region’s many hospital systems and stakeholders.
Such coordination will also require leadership from the business community. The Center said future policies must address so-called social determinants of health, such as race and income. 

“We hope that this report sparks a community-wide discussion on how Greater Houston can become a model for the country for developing a health care system that provides affordable and accessible care, delivers increased quality, is cost efficient and drives economic growth,” said Brett Perlman, the Center’s president and CEO. 

The report was made possible with funding from HCA Houston Healthcare. 

View the complete report and learn more about life sciences in the Houston region. 
 

Related News

Economic Development

Houston Region Asserts Biotech Excellence at BIO International Convention

6/25/25
The Greater Houston Partnership and regional partners showcased Houston’s thriving life sciences and biotechnology ecosystem at the 2025 BIO International Convention in Boston. As the premier annual biotechnology conference in the United States, BIO 2025 drew nearly 20,000 global attendees, offering a powerful platform to highlight the region’s momentum, innovation, and growing opportunities in the sector.    BioHouston, Galveston EDP, Partnership Lake Houston, Pearland EDC, the Sugar Land Office of Economic Development and Tourism and The Woodlands EDP presented the many assets and unique benefits the region offers to biotechnology companies from startup to full-scale, including 8 million square feet of life sciences space, strategic workforce and educational initiatives, as well as an overall favorable approach to incentives and permitting.    "Working alongside the different members of our region and telling the story of the amazing product that Greater Houston has to offer is invigorating," Galveston EDP Executive Director Joshua Owens said. "Being able to showcase our ecosystem to a worldwide audience is an exceptional step toward creating opportunities for the people of Houston."    Recent wins, such as Bionova Scientific's move to The Woodlands and United Therapeutics’ move to Generation Park, serve as testaments to the variety of options for life science businesses in our region. With pronounced capabilities in research and development, manufacturing and innovation, life sciences companies of all kinds can find a welcoming home in the Houston region.    To learn more about our life sciences and biotechnology ecosystem, visit our life sciences page. 
Read More
Health Care

Texas Children’s Hospital, MD Anderson Cancer Center Announce Joint Venture Dedicated to Pediatric Cancer Care

2/21/25
Texas Children’s Hospital and the University of Texas MD Anderson Cancer Center have announced a new joint venture aimed at advancing pediatric cancer treatment.   According to the U.S. Census Bureau, more than 24 percent of Texas' population is under 18 years old, and Texas Oncology reports that over 1,700 children under the age of 20 are diagnosed with cancer, with nearly 200 losing their lives to the disease annually. This makes the need for life-saving treatments more crucial than ever.  By combining the expertise and resources of two of the nation’s leading medical institutions, the partnership will expand access to clinical trials, catalyzing innovative discoveries that can bring treatments to young patients faster.  “The scope and scale of our combined effort will build the world’s preeminent pediatric cancer center, addressing the growing need for excellent patient care and greatly benefiting children with cancer through increased access to care and to clinical trials,” Dr. Peter WT Pisters, president of MD Anderson, said in a press release. “MD Anderson and Texas Children’s offer unique strengths that when brought together will accelerate improved outcomes for patients in Texas and around the world.”  Set to launch in early 2026, the joint venture will prioritize the creation of new facilities designed to enhance the overall patient experience, featuring state-of-the-art medical technology and a “best-in-class healing environment.”  The care team will include 200 Texas Children’s pediatric oncology specialists who are full-time faculty with Baylor College of Medicine and more than 100 MD Anderson pediatric clinicians and researchers.  “This groundbreaking collaboration between two proven leaders in pediatric and cancer care marks the beginning of a new era in the fight against childhood cancer,” Debra Sukin, president and chief executive officer of Texas Children’s, said in the release. “The combined force of our two iconic programs will be led with the nation’s top talent—from clinicians and researchers to nurses and administrative professionals—each committed to realizing the shared mission of eradicating pediatric cancer.”  The initiative will also invest in pediatric oncology education programs, ensuring that the next generation of medical professionals is equipped with the tools and knowledge needed to continue advancing pediatric cancer treatment.  The partnership between Texas Children’s and MD Anderson showcases Houston’s dedication to advancing cancer research and pioneering life-saving treatments. In line with this commitment, MD Anderson furthered its efforts last year through a partnership with Rice University to establish the Cancer Bioengineering Collaborative. This collaboration focuses on both fundamental and translational cancer research, developing cutting-edge technologies for cancer detection and therapy, and securing external funding to support continued research and training.  Learn more about Houston’s life sciences ecosystem. 
Read More

Related Events

Executive Partners